Pentoxifylline and Endometriosis

Hospital Clinic of Barcelona104 enrolled

Overview

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy surgery

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

104

Conditions

Endometriosis-Associated Infertility

Interventions

pentoxifyllineDRUG

800 mg daily for six months

placeboDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Infertile patients having early endometriosis as the only factor of their infertility Exclusion Criteria: * Previous treatment for endometriosis or patients having pelvic disorders in addition to endometriosis

Locations (1)

Hospital Clinic

Barcelona, Barcelona, Spain

Outcomes

Primary Outcomes

Pregnancy rate

Time frame: 6 months follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.